Clinical Drug Induced Liver Injury: Current Diagnostic and Mechanistic Challenges

  • 19k

    Total downloads

  • 80k

    Total views and downloads

About this Research Topic

Submission closed

Background

Drug induced liver injury (DILI) is a rare but complex disease requiring clinical attention by all physicians caring for patients. This Research Topic focuses on clinical and mechanistic considerations of idiosyncratic DILI (iDILI) commonly caused by drugs at mostly recommended daily doses, as opposed to intrinsic DILI due to drugs such as acetaminophen (paracetamol) when taken in intentional or inadvertent overdoses. Idiosyncratic DILI presents as a multifaceted disease, which may mimic all non-drug causes of acute and chronic liver disease. Several key aspects of drug induced hepatotoxicity remain under study:

(1) As iDILI is rare, in contrast to other liver diseases such as alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH), its diagnosis requires a high index of suspicion;
(2) Causality assessment methods (CAMs) are available, including the most commonly used RUCAM (Roussel Uclaf Causality Assessment Method) and rarely applied global introspection methods;
(3) Several global DILI registries are operational to better define the epidemiology of various drugs, including herbal and dietary supplements;
(4) iDILI cases evaluated by a robust CAM are best suited to characterize their clinical features and to help establish valid diagnostic biomarkers;
(5) The exact mechanistic causes of iDILI are difficult to describe due to the lack of appropriate animal models, which are available for intrinsic DILI;
(6) DILI affects not only hepatocytes but also non-parenchymal cells such as Kupffer cells, stellate cells, and sinusoidal endothelial cells with their signaling mediators (interleukins, interferons, and growth factors), which initiate and possibly perpetuate liver injury;
(7) The hepatic microsomal cytochrome P450 (CYP) system metabolizes most drugs to non-toxic products, but occasionally to toxic metabolites and/or reactive oxygen species (ROS), a process called microsomal (oxidative) stress;
(8) Other mechanistic aspects include the formation of haptens on membrane cells and the activation of the innate and adaptive immune systems which can lead to drug-induced autoimmune liver injury;
(9) drugs may modulate the intestinal microbiome, stimulating the production of endotoxins and providing new insights into the gut-liver axis;
(10) Under discussion are circadian rhythms of CYP and DILI, as well as SIRTUIN1 (SIRT1) influencing injury;
(11) Risk factors such as HLA polymorphisms, co-medications, daily drug dose, drug metabolism characteristics, lipophilicity, pre-existing liver disease, and obesity (often with NAFLD) are actively being studied;
(12) The early recognition of DILI in clinical trials remains challenging, and various biomarkers (including exosomes in the blood containing CYPs) are under study for clinical use, although most are as yet poorly validated and do not allow a clear differentiation of DILI from other liver diseases;
(13) New data on treating DILI remain limited; while NAC (N-acetyl cysteine) is highly effective in patients with acetaminophen toxicity, its role in iDILI remains limited.

Clearly, more study is needed to help us understand these and other aspects of detecting and managing DILI in the clinic as well as in drug development, and is the focus of this Research Topic. We hope to receive many manuscripts with balanced views that are refreshing and stimulating, aimed at these controversial topics and ask that all articles have a focus on the recent developments in this field with actual references limited to the last 5 years and historical-type appraisals excluded.

Keywords: Drug induced liver injury, drug hepatotoxicity, Diagnostic biomarkers, Causality assessment methods, Roussel Uclaf Causality Assessment Method

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Frequently asked questions

  • Frontiers' Research Topics are collaborative hubs built around an emerging theme.Defined, managed, and led by renowned researchers, they bring communities together around a shared area of interest to stimulate collaboration and innovation.

    Unlike section journals, which serve established specialty communities, Research Topics are pioneer hubs, responding to the evolving scientific landscape and catering to new communities.

  • The goal of Frontiers' publishing program is to empower research communities to actively steer the course of scientific publishing. Our program was implemented as a three-part unit with fixed field journals, flexible specialty sections, and dynamically emerging Research Topics, connecting communities of different sizes and maturity.

    Research Topics originate from the scientific community. Many of our Research Topics are suggested by existing editorial board members who have identified critical challenges or areas of interest in their field.

  • As an editor, Research Topics will help you build your journal, as well as your community, around emerging, cutting-edge research. As research trailblazers, Research Topics attract high-quality submissions from leading experts all over the world.

    A thriving Research Topic can potentially evolve into a new specialty section if there is sustained interest and a growing community around it.

  • Each Research Topic must be approved by the specialty chief editor, and it falls under the editorial oversight of our editorial boards, supported by our in-house research integrity team. The same standards and rigorous peer review processes apply to articles published as part of a Research Topic as for any other article we publish.

    In 2023, 80% of the Research Topics we published were edited or co-edited by our editorial board members, who are already familiar with their journal's scope, ethos, and publishing model. All other topics are guest edited by leaders in their field, each vetted and formally approved by the specialty chief editor.

  • Publishing your article within a Research Topic with other related articles increases its discoverability and visibility, which can lead to more views, downloads, and citations. Research Topics grow dynamically as more published articles are added, causing frequent revisiting, and further visibility.

    As Research Topics are multidisciplinary, they are cross-listed in several fields and section journals – increasing your reach even more and giving you the chance to expand your network and collaborate with researchers in different fields, all focusing on expanding knowledge around the same important topic.

    Our larger Research Topics are also converted into ebooks and receive social media promotion from our digital marketing team.

  • Frontiers offers multiple article types, but it will depend on the field and section journals in which the Research Topic will be featured. The available article types for a Research Topic will appear in the drop-down menu during the submission process.

    Check available article types here 

  • Yes, we would love to hear your ideas for a topic. Most of our Research Topics are community-led and suggested by researchers in the field. Our in-house editorial team will contact you to talk about your idea and whether you’d like to edit the topic. If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. 

    Suggest your topic here 

  • A team of guest editors (called topic editors) lead their Research Topic. This editorial team oversees the entire process, from the initial topic proposal to calls for participation, the peer review, and final publications.

    The team may also include topic coordinators, who help the topic editors send calls for participation, liaise with topic editors on abstracts, and support contributing authors. In some cases, they can also be assigned as reviewers.

  • As a topic editor (TE), you will take the lead on all editorial decisions for the Research Topic, starting with defining its scope. This allows you to curate research around a topic that interests you, bring together different perspectives from leading researchers across different fields and shape the future of your field. 

    You will choose your team of co-editors, curate a list of potential authors, send calls for participation and oversee the peer review process, accepting or recommending rejection for each manuscript submitted.

  • As a topic editor, you're supported at every stage by our in-house team. You will be assigned a single point of contact to help you on both editorial and technical matters. Your topic is managed through our user-friendly online platform, and the peer review process is supported by our industry-first AI review assistant (AIRA).

  • If you’re an early-stage researcher, we will offer you the opportunity to coordinate your topic, with the support of a senior researcher as the topic editor. This provides you with valuable editorial experience, improving your ability to critically evaluate research articles and enhancing your understanding of the quality standards and requirements for scientific publishing, as well as the opportunity to discover new research in your field, and expand your professional network.

  • Yes, certificates can be issued on request. We are happy to provide a certificate for your contribution to editing a successful Research Topic.

  • Research Topics thrive on collaboration and their multi-disciplinary approach around emerging, cutting-edge themes, attract leading researchers from all over the world.

  • As a topic editor, you can set the timeline for your Research Topic, and we will work with you at your pace. Typically, Research Topics are online and open for submissions within a few weeks and remain open for participation for 6 – 12 months. Individual articles within a Research Topic are published as soon as they are ready.

    Find out more about our Research Topics

  • Our fee support program ensures that all articles that pass peer review, including those published in Research Topics, can benefit from open access – regardless of the author's field or funding situation.

    Authors and institutions with insufficient funding can apply for a discount on their publishing fees. A fee support application form is available on our website.

  • In line with our mission to promote healthy lives on a healthy planet, we do not provide printed materials. All our articles and ebooks are available under a CC-BY license, so you can share and print copies.